Does QuantiFERON Gold Test for Latent TB?
Yes, the QuantiFERON-TB Gold test is specifically designed to detect latent tuberculosis infection (LTBI) by measuring interferon-gamma release in response to M. tuberculosis antigens 1, 2.
How the Test Works
The QuantiFERON-TB Gold test measures a component of cell-mediated immune response rather than delayed-type hypersensitivity (like the tuberculin skin test). It detects the immune response against mycobacterial antigens, which serves as evidence of LTBI in asymptomatic persons 1. The test is FDA-approved and functions as an ex vivo whole blood antigen-stimulated interferon-gamma release assay 1.
Clinical Applications
IGRAs including QuantiFERON-TB Gold may be used as aids in diagnosing M. tuberculosis infection, for surveillance purposes, and to identify persons likely to benefit from treatment 2. The test can detect both:
- Latent tuberculosis infection (the primary indication)
- Active tuberculosis infection (though this requires additional clinical and microbiological confirmation)
Test Performance Characteristics
The test demonstrates:
- Specificity: 86% (pooled across studies), meaning it reliably rules out non-TB cases 3
- Sensitivity: 49% (pooled), indicating a risk of false negatives 3
- Negative predictive value: 72%, making negative results reasonably reliable 3
- Positive predictive value: 61%, meaning positive results should be interpreted with clinical context 3
Performance Varies by Population
Sensitivity differs substantially across risk groups 3:
- HIV patients: 60%
- Healthcare workers: 55%
- TB contacts: 48%
- Children: 43%
- Rheumatoid arthritis patients: 39%
- Inflammatory bowel disease patients: 15%
Key Clinical Considerations
The test cannot distinguish between latent and active TB based on quantitative values alone 4. While higher interferon-gamma levels may suggest active disease in test-positive individuals, substantial overlap exists between LTBI and active TB results 4. Therefore, positive results require clinical correlation including:
- Symptom assessment (cough, fever, weight loss, night sweats)
- Chest radiography
- Sputum examination if active disease suspected
Common pitfall: The test has an indeterminate rate of approximately 1.7% 5, which can occur due to:
- Immunosuppression
- Technical issues
- Inadequate immune response to mitogen control
Advantages Over Tuberculin Skin Test
The QuantiFERON test offers several benefits:
- Single patient visit required (no return visit for reading) 5
- Not affected by prior BCG vaccination 2
- More specific than TST (agreement between tests is only fair to moderate, kappa 0.27-0.41) 6, 7
- No booster phenomenon from repeated testing
The newer QuantiFERON-TB Gold Plus version includes an additional tube (TB2) with shorter peptides that stimulate CD8 T-cells, showing substantial agreement with the older In-Tube version 8.